_version_ 1783680153433407488
author Moll, Matthew
Zon, Rebecca L.
Sylvester, Katelyn W.
Rimsans, Jessica
Chen, Evan C.
Ghosh, Auyon J.
Abston, Eric
Kim, Andy
Rutherford, Henry
Mitre, Xhoi
Hakim, Aaron
Connell, Nathan T.
Battinelli, Elisabeth
Fredenburgh, Laura E.
Baron, Rebecca M.
Hobbs, Brian D.
Cho, Michael H.
Mittleman, Murray A.
Woolley, Ann E.
Connors, Jean M.
author_facet Moll, Matthew
Zon, Rebecca L.
Sylvester, Katelyn W.
Rimsans, Jessica
Chen, Evan C.
Ghosh, Auyon J.
Abston, Eric
Kim, Andy
Rutherford, Henry
Mitre, Xhoi
Hakim, Aaron
Connell, Nathan T.
Battinelli, Elisabeth
Fredenburgh, Laura E.
Baron, Rebecca M.
Hobbs, Brian D.
Cho, Michael H.
Mittleman, Murray A.
Woolley, Ann E.
Connors, Jean M.
author_sort Moll, Matthew
collection PubMed
description
format Online
Article
Text
id pubmed-8053596
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80535962021-04-19 Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis Moll, Matthew Zon, Rebecca L. Sylvester, Katelyn W. Rimsans, Jessica Chen, Evan C. Ghosh, Auyon J. Abston, Eric Kim, Andy Rutherford, Henry Mitre, Xhoi Hakim, Aaron Connell, Nathan T. Battinelli, Elisabeth Fredenburgh, Laura E. Baron, Rebecca M. Hobbs, Brian D. Cho, Michael H. Mittleman, Murray A. Woolley, Ann E. Connors, Jean M. Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2021-07 2021-04-19 /pmc/articles/PMC8053596/ /pubmed/33940309 http://dx.doi.org/10.1016/j.thromres.2021.04.009 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editors-in-Chief
Moll, Matthew
Zon, Rebecca L.
Sylvester, Katelyn W.
Rimsans, Jessica
Chen, Evan C.
Ghosh, Auyon J.
Abston, Eric
Kim, Andy
Rutherford, Henry
Mitre, Xhoi
Hakim, Aaron
Connell, Nathan T.
Battinelli, Elisabeth
Fredenburgh, Laura E.
Baron, Rebecca M.
Hobbs, Brian D.
Cho, Michael H.
Mittleman, Murray A.
Woolley, Ann E.
Connors, Jean M.
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
title Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
title_full Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
title_fullStr Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
title_full_unstemmed Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
title_short Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
title_sort intermediate versus standard dose heparin prophylaxis in covid-19 icu patients: a propensity score-matched analysis
topic Letter to the Editors-in-Chief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053596/
https://www.ncbi.nlm.nih.gov/pubmed/33940309
http://dx.doi.org/10.1016/j.thromres.2021.04.009
work_keys_str_mv AT mollmatthew intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT zonrebeccal intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT sylvesterkatelynw intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT rimsansjessica intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT chenevanc intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT ghoshauyonj intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT abstoneric intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT kimandy intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT rutherfordhenry intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT mitrexhoi intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT hakimaaron intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT connellnathant intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT battinellielisabeth intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT fredenburghlaurae intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT baronrebeccam intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT hobbsbriand intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT chomichaelh intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT mittlemanmurraya intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT woolleyanne intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis
AT connorsjeanm intermediateversusstandarddoseheparinprophylaxisincovid19icupatientsapropensityscorematchedanalysis